As otolaryngologists are performing more procedures on an in-office basis, more are also using conscious sedation in the clinic setting.
New Paradigms Emerging in Diagnosis, Management of Thyroid Cancer
Former AAOA Heads Take on Allergic Rhinitis
An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.
Drug Marketing: Different Impacts on Different Physicians
Pharmaceutical company representatives (PCRs) are as ubiquitous in otolaryngologists’ offices as seasonal allergies and ear infections.
A Swing of the Pendulum?
For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
Sudden Sensorineural Hearing Loss: Hard to Define, Hard to Treat
Sudden sensorineural hearing loss (SSHL) has stumped otolaryngologists for decades.
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
Temporary Trial May Improve Compliance with CPAP
Continuous positive airway pressure (CPAP) is the standard first-line approach for moderate to severe obstructive sleep apnea.
Proposed Vial Mixing Standard May Have Adverse Effects for Otolaryngologists
Standards proposed by the United States Pharmacopeia (USP) for the compounding of sterile medication could be applied to vial mixing in the office.
Thinking of Adding Hearing Aids to Your Practice? Experts Dispense Advice
An estimated 31 million Americans are affected by some level of hearing loss and, as the population ages, that number will continue to rise.
- « Previous Page
- 1
- …
- 311
- 312
- 313
- 314
- 315
- …
- 322
- Next Page »